- Filed
- Apr 24, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 23, 2025 | 24.61M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $3.39M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $807K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.11B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.15B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.24B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.28B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 24.56M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $11.77M |
| Capex | Q1 2025 · Mar 31, 2024 | $25.28M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $59.42M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $943.02M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $933.8M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.93 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.93 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $50.46M |
| Net Income | Q1 2025 · Mar 31, 2024 | $22.85M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $52.09M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $93.27M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $94.56M |